Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Sex-specific differences in endoplasmic reticulum aminopeptidase 1 modulation influence blood pressure and renin-angiotensin system responses.

Ranjit S, Wong JY, Tan JW, Sin Tay C, Lee JM, Yin Han Wong K, Pojoga LH, Brooks DL, Garza AE, Maris SA, Katayama IA, Williams JS, Rivera A, Adler GK, Williams GH, Romero JR.

JCI Insight. 2019 Nov 1;4(21). pii: 129615. doi: 10.1172/jci.insight.129615.

2.

Serum Lipocalin 2 (Neutrophil Gelatinase-Associated Lipocalin) in Relation to Biomarkers of Inflammation and Cardiac Stretch During Activation of the Renin-Angiotensin-Aldosterone System in Human Immunodeficiency Virus.

Bogorodskaya M, Fitch KV, Burdo TH, Maehler P, Easly RM, Murray GR, Feldpausch M, Adler GK, Grinspoon SK, Srinivasa S.

J Infect Dis. 2019 Sep 26;220(9):1420-1424. doi: 10.1093/infdis/jiz346.

PMID:
31298286
3.

Higher urinary cortisol levels associate with increased cardiovascular risk.

Haas AV, Hopkins PN, Brown NJ, Pojoga LH, Williams JS, Adler GK, Williams GH.

Endocr Connect. 2019 Jun 1;8(6):634-640. doi: 10.1530/EC-19-0182.

4.

Aldosterone Modulates the Mechanistic Target of Rapamycin Signaling in Male Mice.

Brooks DL, Garza AE, Katayama IA, Romero JR, Adler GK, Pojoga LH, Williams GH.

Endocrinology. 2019 Apr 1;160(4):716-728. doi: 10.1210/en.2018-00989.

PMID:
30726893
5.

Aldosterone, the Mineralocorticoid Receptor and Mechanisms of Cardiovascular Disease.

Young MJ, Adler GK.

Vitam Horm. 2019;109:361-385. doi: 10.1016/bs.vh.2018.10.003. Epub 2018 Dec 1.

PMID:
30678863
6.

Sex Differences in Coronary Microvascular Function in Individuals With Type 2 Diabetes.

Haas AV, Rosner BA, Kwong RY, Rao AD, Garg R, Di Carli MF, Adler GK.

Diabetes. 2019 Mar;68(3):631-636. doi: 10.2337/db18-0650. Epub 2018 Nov 8.

7.

Histone demethylase LSD1 deficiency and biological sex: impact on blood pressure and aldosterone production.

Huang Y, Ting PY, Yao TM, Homma T, Brooks D, Katayama Rangel I, Adler GK, Romero JR, Williams JS, Pojoga LH, Williams GH.

J Endocrinol. 2019 Feb 1;240(2):111-122. doi: 10.1530/JOE-18-0247.

8.

Significant Association of Aldosterone and Liver Fat Among HIV-Infected Individuals With Metabolic Dysregulation.

Srinivasa S, Fitch KV, Quadri N, Maehler P, O'Malley TK, Martinez-Salazar EL, Burdo TH, Feldpausch M, Torriani M, Adler GK, Grinspoon SK.

J Endocr Soc. 2018 Sep 3;2(10):1147-1157. doi: 10.1210/js.2018-00194. eCollection 2018 Oct 1.

9.

The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Vaidya A, Mulatero P, Baudrand R, Adler GK.

Endocr Rev. 2018 Dec 1;39(6):1057-1088. doi: 10.1210/er.2018-00139. Review.

PMID:
30124805
10.

Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer.

Wu D, Hu D, Chen H, Shi G, Fetahu IS, Wu F, Rabidou K, Fang R, Tan L, Xu S, Liu H, Argueta C, Zhang L, Mao F, Yan G, Chen J, Dong Z, Lv R, Xu Y, Wang M, Ye Y, Zhang S, Duquette D, Geng S, Yin C, Lian CG, Murphy GF, Adler GK, Garg R, Lynch L, Yang P, Li Y, Lan F, Fan J, Shi Y, Shi YG.

Nature. 2018 Jul;559(7715):637-641. doi: 10.1038/s41586-018-0350-5. Epub 2018 Jul 18.

11.

Oxytocin response to controlled dietary sodium and angiotensin II among healthy individuals.

Srinivasa S, Aulinas A, O'Malley T, Maehler P, Adler GK, Grinspoon SK, Lawson EA.

Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E671-E675. doi: 10.1152/ajpendo.00190.2018. Epub 2018 Jun 26.

12.

Biological Sex Modulates the Adrenal and Blood Pressure Responses to Angiotensin II.

Shukri MZ, Tan JW, Manosroi W, Pojoga LH, Rivera A, Williams JS, Seely EW, Adler GK, Jaffe IZ, Karas RH, Williams GH, Romero JR.

Hypertension. 2018 Jun;71(6):1083-1090. doi: 10.1161/HYPERTENSIONAHA.117.11087. Epub 2018 Apr 23.

13.

Randomized, Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Metabolic and Inflammatory Indices in HIV.

Srinivasa S, Fitch KV, Wong K, O'Malley TK, Maehler P, Branch KL, Looby SE, Burdo TH, Martinez-Salazar EL, Torriani M, Lyons SH, Weiss J, Feldpausch M, Stanley TL, Adler GK, Grinspoon SK.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2376-2384. doi: 10.1210/jc.2018-00330.

14.

A randomized intervention study to evaluate the effect of calcitriol therapy on the renin-angiotensin system in diabetes.

Zaheer S, Taquechel K, Brown JM, Adler GK, Williams JS, Vaidya A.

J Renin Angiotensin Aldosterone Syst. 2018 Jan-Mar;19(1):1470320317754178. doi: 10.1177/1470320317754178.

15.

Caloric restriction improves glucose homeostasis, yet increases cardiometabolic risk in caveolin-1-deficient mice.

Mayurasakorn K, Hasanah N, Homma T, Homma M, Rangel IK, Garza AE, Romero JR, Adler GK, Williams GH, Pojoga LH.

Metabolism. 2018 Jun;83:92-101. doi: 10.1016/j.metabol.2018.01.012. Epub 2018 Feb 2.

PMID:
29410348
16.

Excessive Adiposity and Metabolic Dysfunction Relate to Reduced Natriuretic Peptide During RAAS Activation in HIV.

Murphy CA, Fitch KV, Feldpausch M, Maehler P, Wong K, Torriani M, Adler GK, Grinspoon SK, Srinivasa S.

J Clin Endocrinol Metab. 2018 Apr 1;103(4):1558-1565. doi: 10.1210/jc.2017-02198.

17.

Dysregulated aldosterone secretion in persons of African descent with endothelin-1 gene variants.

Tan JW, Gupta T, Manosroi W, Yao TM, Hopkins PN, Williams JS, Adler GK, Romero JR, Williams GH.

JCI Insight. 2017 Dec 7;2(23). pii: 95992. doi: 10.1172/jci.insight.95992.

18.

Combined Salt and Caloric Restrictions: Potential Adverse Outcomes.

Homma T, Homma M, Huang Y, Mayurasakorn K, Rodi NM, Hamid AAA, Hurwitz S, Yao T, Adler GK, Pojoga LH, Williams GH, Romero JR.

J Am Heart Assoc. 2017 Oct 11;6(10). pii: e005374. doi: 10.1161/JAHA.116.005374.

19.

Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion.

Zaheer S, Brown JM, Connors M, Williams JS, Adler GK, Vaidya A.

Int J Endocrinol. 2017;2017:4138783. doi: 10.1155/2017/4138783. Epub 2017 Jul 20.

20.

Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus.

Bayomy O, Rao AD, Garg R, Vaidya A, Kotin AR, Reiber B, Nijmeijer S, Di Carli MF, Jerosch-Herold M, Kwong RY, Adler GK.

Metab Syndr Relat Disord. 2017 Aug;15(6):269-275. doi: 10.1089/met.2017.0031. Epub 2017 May 15.

21.

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

Seccia TM, Caroccia B, Adler GK, Maiolino G, Cesari M, Rossi GP.

Hypertension. 2017 Apr;69(4):545-550. doi: 10.1161/HYPERTENSIONAHA.116.08956. Review. No abstract available.

22.

Regulation of aldosterone secretion by mineralocorticoid receptor-mediated signaling.

Chong C, Hamid A, Yao T, Garza AE, Pojoga LH, Adler GK, Romero JR, Williams GH.

J Endocrinol. 2017 Mar;232(3):525-534. doi: 10.1530/JOE-16-0452. Epub 2017 Jan 17.

23.

"Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study.

Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A.

Ann Intern Med. 2016 Oct 18;165(8):533-542. doi: 10.7326/M16-0547. Epub 2016 Aug 2.

24.

Differential Effects of Two Antialdosterone Agents on Glycemic Control.

Garg R, Adler GK.

Endocrinology. 2016 Oct;157(10):3767-3768. No abstract available.

25.

Caveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis.

Baudrand R, Gupta N, Garza AE, Vaidya A, Leopold JA, Hopkins PN, Jeunemaitre X, Ferri C, Romero JR, Williams J, Loscalzo J, Adler GK, Williams GH, Pojoga LH.

J Am Heart Assoc. 2016 Sep 28;5(10). pii: e003845. doi: 10.1161/JAHA.116.003845.

26.

Effects of Sodium Restriction on Activation of the Renin-Angiotensin-Aldosterone System and Immune Indices During HIV Infection.

Srinivasa S, Burdo TH, Williams KC, Mitten EK, Wong K, Fitch KV, Stanley T, Adler GK, Grinspoon SK.

J Infect Dis. 2016 Nov 1;214(9):1336-1340. Epub 2016 Aug 22.

27.

A prevalent caveolin-1 gene variant is associated with the metabolic syndrome in Caucasians and Hispanics.

Baudrand R, Goodarzi MO, Vaidya A, Underwood PC, Williams JS, Jeunemaitre X, Hopkins PN, Brown N, Raby BA, Lasky-Su J, Adler GK, Cui J, Guo X, Taylor KD, Chen YD, Xiang A, Raffel LJ, Buchanan TA, Rotter JI, Williams GH, Pojoga LH.

Metabolism. 2015 Dec;64(12):1674-81. doi: 10.1016/j.metabol.2015.09.005. Epub 2015 Sep 12.

28.

Baroreflex Sensitivity Impairment During Hypoglycemia: Implications for Cardiovascular Control.

Rao AD, Bonyhay I, Dankwa J, Baimas-George M, Kneen L, Ballatori S, Freeman R, Adler GK.

Diabetes. 2016 Jan;65(1):209-15. doi: 10.2337/db15-0871. Epub 2015 Oct 5.

29.

Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects.

Baudrand R, Pojoga LH, Vaidya A, Garza AE, Vöhringer PA, Jeunemaitre X, Hopkins PN, Yao TM, Williams J, Adler GK, Williams GH.

Circulation. 2015 Nov 10;132(19):1825-33. doi: 10.1161/CIRCULATIONAHA.115.016759. Epub 2015 Oct 2.

30.

Thalamic mechanisms underlying alpha-delta sleep with implications for fibromyalgia.

Vijayan S, Klerman EB, Adler GK, Kopell NJ.

J Neurophysiol. 2015 Sep;114(3):1923-30. doi: 10.1152/jn.00280.2015. Epub 2015 Aug 5.

31.

Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.

Pojoga LH, Yao TM, Opsasnick LA, Siddiqui WT, Reslan OM, Adler GK, Williams GH, Khalil RA.

J Pharmacol Exp Ther. 2015 Oct;355(1):32-47. doi: 10.1124/jpet.115.226043. Epub 2015 Jul 16.

32.

Critical Role of Striatin in Blood Pressure and Vascular Responses to Dietary Sodium Intake.

Garza AE, Pojoga LH, Moize B, Hafiz WM, Opsasnick LA, Siddiqui WT, Horenstein M, Adler GK, Williams GH, Khalil RA.

Hypertension. 2015 Sep;66(3):674-80. doi: 10.1161/HYPERTENSIONAHA.115.05600. Epub 2015 Jul 13.

33.

RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.

Srinivasa S, Fitch KV, Wong K, Torriani M, Mayhew C, Stanley T, Lo J, Adler GK, Grinspoon SK.

J Clin Endocrinol Metab. 2015 Aug;100(8):2873-82. doi: 10.1210/jc.2015-1461. Epub 2015 Jun 18.

34.

Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders.

Garg R, Adler GK.

Curr Hypertens Rep. 2015 Jul;17(7):52. doi: 10.1007/s11906-015-0567-8. Review.

PMID:
26068659
35.

Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase.

Urbanet R, Nguyen Dinh Cat A, Feraco A, Venteclef N, El Mogrhabi S, Sierra-Ramos C, Alvarez de la Rosa D, Adler GK, Quilliot D, Rossignol P, Fallo F, Touyz RM, Jaisser F.

Hypertension. 2015 Jul;66(1):149-57. doi: 10.1161/HYPERTENSIONAHA.114.04981. Epub 2015 May 11.

PMID:
25966493
36.

Effect of mineralocorticoid receptor blockade on hippocampal-dependent memory in adults with obesity.

Rotenstein LS, Sheridan M, Garg R, Adler GK.

Obesity (Silver Spring). 2015 Jun;23(6):1136-42. doi: 10.1002/oby.21104. Epub 2015 May 9.

37.

Quantifying Pituitary-Adrenal Dynamics and Deconvolution of Concurrent Cortisol and Adrenocorticotropic Hormone Data by Compressed Sensing.

Faghih RT, Dahleh MA, Adler GK, Klerman EB, Brown EN.

IEEE Trans Biomed Eng. 2015 Oct;62(10):2379-88. doi: 10.1109/TBME.2015.2427745. Epub 2015 Apr 29.

38.

Variants in striatin gene are associated with salt-sensitive blood pressure in mice and humans.

Garza AE, Rariy CM, Sun B, Williams J, Lasky-Su J, Baudrand R, Yao T, Moize B, Hafiz WM, Romero JR, Adler GK, Ferri C, Hopkins PN, Pojoga LH, Williams GH.

Hypertension. 2015 Jan;65(1):211-217. doi: 10.1161/HYPERTENSIONAHA.114.04233. Epub 2014 Nov 3.

39.

Biological time series analysis using a context free language: applicability to pulsatile hormone data.

Dean DA 2nd, Adler GK, Nguyen DP, Klerman EB.

PLoS One. 2014 Sep 3;9(9):e104087. doi: 10.1371/journal.pone.0104087. eCollection 2014.

40.

Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.

Garg R, Rao AD, Baimas-George M, Hurwitz S, Foster C, Shah RV, Jerosch-Herold M, Kwong RY, Di Carli MF, Adler GK.

Diabetes. 2015 Jan;64(1):236-42. doi: 10.2337/db14-0670. Epub 2014 Aug 14.

41.

Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.

Barrett Mueller K, Lu Q, Mohammad NN, Luu V, McCurley A, Williams GH, Adler GK, Karas RH, Jaffe IZ.

Endocrinology. 2014 Nov;155(11):4461-72. doi: 10.1210/en.2014-1270. Epub 2014 Jul 22.

42.

Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk.

Brown JM, Underwood PC, Ferri C, Hopkins PN, Williams GH, Adler GK, Vaidya A.

Hypertension. 2014 Jun;63(6):1205-11. doi: 10.1161/HYPERTENSIONAHA.114.03231. Epub 2014 Mar 24.

43.

Deconvolution of serum cortisol levels by using compressed sensing.

Faghih RT, Dahleh MA, Adler GK, Klerman EB, Brown EN.

PLoS One. 2014 Jan 28;9(1):e85204. doi: 10.1371/journal.pone.0085204. eCollection 2014.

44.

Long-term dietary sodium restriction increases adiponectin expression and ameliorates the proinflammatory adipokine profile in obesity.

Baudrand R, Lian CG, Lian BQ, Ricchiuti V, Yao TM, Li J, Williams GH, Adler GK.

Nutr Metab Cardiovasc Dis. 2014 Jan;24(1):34-41. doi: 10.1016/j.numecd.2013.07.004. Epub 2013 Oct 12.

45.

Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice.

Pojoga LH, Yao TM, Opsasnick LA, Garza AE, Reslan OM, Adler GK, Williams GH, Khalil RA.

J Pharmacol Exp Ther. 2014 Feb;348(2):260-70. doi: 10.1124/jpet.113.209189. Epub 2013 Nov 26.

46.

Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.

Brown JM, Williams JS, Luther JM, Garg R, Garza AE, Pojoga LH, Ruan DT, Williams GH, Adler GK, Vaidya A.

Hypertension. 2014 Feb;63(2):273-80. doi: 10.1161/HYPERTENSIONAHA.113.01910. Epub 2013 Nov 4.

47.

Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.

Garg R, Kneen L, Williams GH, Adler GK.

Diabetes Obes Metab. 2014 Mar;16(3):268-72. doi: 10.1111/dom.12224. Epub 2013 Oct 31.

48.

Mineralocorticoid receptor throughout the vessel: a key to vascular dysfunction in obesity.

Pojoga LH, Baudrand R, Adler GK.

Eur Heart J. 2013 Dec;34(45):3475-7. doi: 10.1093/eurheartj/eht158. Epub 2013 May 10. No abstract available.

49.

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

Rao AD, Shah RV, Garg R, Abbasi SA, Neilan TG, Perlstein TS, Di Carli MF, Jerosch-Herold M, Kwong RY, Adler GK.

Am J Cardiol. 2013 Jul 1;112(1):73-8. doi: 10.1016/j.amjcard.2013.02.060. Epub 2013 Apr 15.

50.

Abnormal aldosterone physiology and cardiometabolic risk factors.

Vaidya A, Underwood PC, Hopkins PN, Jeunemaitre X, Ferri C, Williams GH, Adler GK.

Hypertension. 2013 Apr;61(4):886-93. doi: 10.1161/HYPERTENSIONAHA.111.00662. Epub 2013 Feb 11.

Supplemental Content

Loading ...
Support Center